BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12
306 results:

  • 1. Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells.
    Mikhael S; Kurdi A; Khoueiry-Zgheib N; Tahtouh R; Nasr R; Hilal G
    PLoS One; 2024; 19(3):e0298127. PubMed ID: 38489280
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term use of anti-cholesterol drugs and cancer risks in a Japanese population.
    Okita Y; Sobue T; Zha L; Kitamura T; Iwasaki M; Inoue M; Yamaji T; Tsugane S; Sawada N
    Sci Rep; 2024 Feb; 14(1):2896. PubMed ID: 38316869
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Apparent diffusion coefficient histogram in the differentiation of benign and malignant testicular tumors.
    Minh ND; Hung ND; Tuan TA; Hien MM; Tuan HX; Duc NM
    Int J Med Sci; 2024; 21(2):200-206. PubMed ID: 38169660
    [No Abstract]    [Full Text] [Related]  

  • 4. Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
    Zebic DS; Tjokrowidjaja A; Francis KE; Friedlander M; Gebski V; Lortholary A; Joly F; Hasenburg A; Mirza M; Denison U; Cecere SC; Ferrero A; Pujade-Lauraine E; Lee CK
    Br J Cancer; 2024 Feb; 130(3):425-433. PubMed ID: 38097739
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ultrasonographic Features of Nonneoplastic Protrusions in Pancreatic Cysts by Contrast-Enhanced Endoscopic Ultrasound.
    Hisa T; Kudo A; Shimizu T; Nishiyama S; Yamada T; Osera S; Fukushima H; Tomori A
    Pancreas; 2023 Jul; 52(6):e328-e334. PubMed ID: 38015069
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data.
    Jia K; Kundrot S; Palchuk MB; Warnick J; Haapala K; Kaplan ID; Rinard M; Appelbaum L
    EBioMedicine; 2023 Dec; 98():104888. PubMed ID: 38007948
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A systematic review meta-analysis and meta-regression on the implications of an aberrant right hepatic artery in patients undergoing pancreaticoduodenectomy for the treatment of malignant disease.
    Chorti A; Bontinis V; Bontinis A; Alifieris CE; Chatziantoniou G; Karlafti E; Michalopoulos A; Paramythiotis D
    Minerva Surg; 2024 Feb; 79(1):82-91. PubMed ID: 37955856
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical predictors and significance of adherent periadrenal fat in laparoscopic adrenalectomy.
    Olcucuoglu E; Senel S; Uzun E; Ceviz K; Gultekin H; Arabaci HB; Koudonas A; Aydin C
    BMC Urol; 2023 Nov; 23(1):176. PubMed ID: 37915035
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.
    Tumati A; Egan CE; Lee-Saxton YJ; Marshall TE; Lee J; Jain K; Heymann JJ; Gokozan H; Azar SA; Schwarz J; Keutgen XM; Laird AM; Beninato T; Zarnegar R; Fahey TJ; Finnerty BM
    Surgery; 2024 Jan; 175(1):234-240. PubMed ID: 37907382
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.
    Samain R; Maiques O; Monger J; Lam H; Candido J; George S; Ferrari N; KohIhammer L; Lunetto S; Varela A; Orgaz JL; Vilardell F; Olsina JJ; Matias-Guiu X; Sarker D; Biddle A; Balkwill FR; Eyles J; Wilkinson RW; Kocher HM; Calvo F; Wells CM; Sanz-Moreno V
    Sci Adv; 2023 Oct; 9(42):eadi0244. PubMed ID: 37851808
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
    Wainberg ZA; Melisi D; Macarulla T; Pazo Cid R; Chandana SR; De La Fouchardière C; Dean A; Kiss I; Lee WJ; Goetze TO; Van Cutsem E; Paulson AS; Bekaii-Saab T; Pant S; Hubner RA; Xiao Z; Chen H; Benzaghou F; O'Reilly EM
    Lancet; 2023 Oct; 402(10409):1272-1281. PubMed ID: 37708904
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Adherence of PARP inhibitor for frontline maintenance therapy in primary epithelial ovarian cancer: a cross-sectional survey.
    Kim JH; Lee Y; Kim DY; Kim S; Seo SS; Kang S; Park SY; Lim MC
    J Gynecol Oncol; 2024 Jan; 35(1):e3. PubMed ID: 37681357
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Application of thyroglobulin and anti-thyroglobulin antibody combined with emission computed tomography in the adjuvant diagnosis of differentiated thyroid carcinoma.
    Jiang N; Jiao B; Zhang L; Li J; Li Y; Lin C
    Ann Med; 2023 Dec; 55(1):2232372. PubMed ID: 37435919
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association between the Environmental Quality Index and Textbook Outcomes Among Medicare Beneficiaries Undergoing Surgery for Early-Stage Pancreatic Adenocarcinoma.
    Shaikh CF; Woldesenbet S; Munir MM; Moazzam Z; Endo Y; Alaimo L; Azap L; Yang J; Katayama E; Lima HA; Dawood Z; Pawlik TM
    J Gastrointest Surg; 2023 Sep; 27(9):1883-1892. PubMed ID: 37340109
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
    Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
    Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A combined clinical and genetic model for predicting risk of ovarian cancer.
    Dite GS; Spaeth E; Murphy NM; Allman R
    Eur J Cancer Prev; 2023 Jan; 32(1):57-64. PubMed ID: 36503897
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women.
    Peduzzi G; Archibugi L; Katzke V; Gentiluomo M; Capurso G; Milanetto AC; Gazouli M; Goetz M; Brenner H; Vermeulen RCH; Talar-Wojnarowska R; Vanella G; Tavano F; Lucchesi M; Mohelnikova-Duchonova B; Chen X; Kiudelis V; Hegyi P; Oliverius M; Stocker H; Stornello C; Vodickova L; Souček P; Neoptolemos JP; Testoni SGG; Morelli L; Lawlor RT; Basso D; Izbicki JR; Ermini S; Kupcinskas J; Pezzilli R; Boggi U; van Laarhoven HWM; Szentesi A; Erőss B; Capretti G; Schöttker B; Skieceviciene J; Aoki MN; van Eijck CHJ; Cavestro GM; Canzian F; Campa D
    Sci Rep; 2022 Oct; 12(1):18100. PubMed ID: 36302831
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Diagnostic accuracy of fine needle aspiration biopsy versus postoperative histopathology for diagnosing thyroid malignancy.
    Aliyev A; Aliyeva I; Giammarile F; Talibova N; Aliyeva G; Novruzov F
    Endocrinol Diabetes Metab; 2022 Nov; 5(6):e373. PubMed ID: 36149057
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Novel approach of desensitization in allergic reaction to Olaparib.
    Beurer BM; Sprenger LM; Graneß K; Feldmann F; Warnke U; Biersack MG; Fischer D
    J Oncol Pharm Pract; 2023 Jun; 29(4):967-970. PubMed ID: 36128835
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.